publication . Article . 2004

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001)

Mutnick, A. H.; Rhomberg, P. R.; Sader, Helio S. [UNIFESP]; Jones, R. N.;
Open Access
  • Published: 16 Jan 2004 Journal: Journal of Antimicrobial Chemotherapy, volume 53, pages 290-296 (eissn: 1460-2091, Copyright policy)
  • Publisher: Oxford University Press (OUP)
  • Country: Mozambique
Made available in DSpace on 2016-01-24T12:34:15Z (GMT). No. of bitstreams: 0 Previous issue date: 2004-02-01 Background: the MYSTIC Programme is a global, longitudinal antimicrobial surveillance network of hospitals that frequently utilize carbapenems. One aspect of the programme is the ability to capture antimicrobial consumption data from participating institutions. the current report evaluates these relationships for Enterobacteriaceae and Pseudomonas aeruginosa over the initial 3 year period of the programme in the USA.Methods: Between 10 and 15 medical centres participated during 1999-2001, each submitting up to 200 isolates/year (7003 strains overall). Eva...
free text keywords: defined daily doses, correlations, carbapenems, P. aeruginosa, Meropenem, medicine.drug, medicine, Defined daily dose, Imipenem, Antibiotic resistance, business.industry, business, Cefepime, Ceftazidime, Microbiology, Ciprofloxacin, Antimicrobial
Related Organizations
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue